Clinical Trials Browser

Esophageal Neoplasms

NCT03301454 2026-03-18

E-DIS2

Phase 2 Terminated

15 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05500391 2026-03-18

SUR-CAN

Phase 2 Recruiting

88 enrolled

CNSEndocrineGastrointestinalNETSarcoma

Carcinosarcoma, Glioma, Seminoma, Adenocarcinoma, Clear Cell, Carcinoma, Small Cell, Sex Cord-Gonadal Stromal Tumors, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

Clinical Trials

PROTECT

E-DIS2

SUR-CAN

SCOTI

SAMe in Prevention of Oxaliplatin-associated Liver Injury

IAPETUS

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Vebotolimab Combined With Ptorlimab for EGFR-positive Refractory Advanced Biliary Tract Malignancies

FAPDIG

MA-CRC-II-018

METCAP

TERTIO

Reinforced Pancreaticojejunostomy With or Without glubran2

CKNO-HEP

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer

NeuroPrevPTSD

Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcinoma

ACT-GI

A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer

TRIUNITE-07

TRIUNITE-08

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

LAVA-CRLM

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

HEARTS Trial for Thoracic Cancers

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Palbociclib and Cetuximab in Metastatic Colorectal Cancer

PEGASUS

Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea

A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement

HAIC-quad

PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence

CAIRE

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

MAESTRO

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01）

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

IGNITE

PILDI

NICHE

Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib